Cvs Group Plc logo

Cvs Group Plc(OTC) CVSGF

Market Cap$1.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)+21%
5 Year-51%
1 Year+2%
1 Month+0%
$16.60
+0.00%
+0.00Today
Cvs Group Plc last closing stock price
MetricPriceDate
Last closeUSD 16.602026-09-29
Cvs Group Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 16.602026-08-13
1 month+0%USD 16.602026-08-13
3 month+0.3%USD 16.552026-05-26
Year to date+2.34%USD 16.222025-12-12
1 year+2.47%USD 16.202025-09-09
3 year-29.12%USD 23.422023-09-19
5 year-50.52%USD 33.552021-08-02
Since inception+20.73%USD 13.752018-03-23

Cvs Group Plc Financials at a Glance

Market Cap

$1.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£1.64B

Net Income (TTM)

£43.84M

EPS (TTM)

$0.33

P/E Ratio

50.63

Dividend

$0.11

Beta (Volatility)

-0.00 (Low)

Price

$16.60

Volume

13,300

Open

$16.60

Previous Close

$16.60

Daily Range

$16.60 - $16.60

52-Week Range

$14.50 - $17.22

Estimated Earnings Date

Sep 24, 2026

CVSGF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cvs Group Plc

CVS Group plc is a leading provider of comprehensive animal care services, operating through a network of veterinary practices, diagnostic laboratories, and online retail platforms. The company is dedicated to enhancing the health and well-being of pets across the UK, the Netherlands, and the Republic of Ireland.

Products and Services
  • Veterinary treatment and diagnostic services
  • Pet cremation and clinical waste disposal
  • Online retail of pet supplies and pharmaceuticals
Growth Outlook
  • Revenue of £356.8 million reported in the latest quarter
  • Net income increased to £7.8 million, reflecting operational efficiency
  • Expansion plans include acquiring additional veterinary practices
Financial Highlights
  • Trailing twelve months (TTM) revenue of £1.4 billion
  • Operating income margin at 10.4%, indicating strong profitability
  • Dividend yield of 0.65%, providing a return to shareholders
CVS Group plc operates in the healthcare sector, specifically within the medical care facilities industry. The company has established a significant presence with 472 veterinary clinics, 3 laboratories, and 7 crematoria. The diverse range of services offered positions CVS Group as a one-stop solution for pet care needs, catering to both veterinary establishments and pet owners. The growth outlook for CVS Group is promising, with recent quarterly results showcasing a revenue increase and a notable rise in net income. The company is actively pursuing expansion opportunities, which may further enhance its market position. Financially, CVS Group has demonstrated resilience, with a solid operating income margin and a commitment to returning value to shareholders through dividends. Overall, CVS Group plc presents a compelling opportunity for investors interested in the healthcare sector, particularly in the growing field of animal care services. The company's strategic initiatives and robust financial performance underscore its potential for continued growth and profitability.
AI Generated • Sep 20, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

9,000

CEO

Richard William Mark Fairman

Website

www.cvsgroupplc.com

Headquarters

Diss, NO IP22 4ER, GB

CVSGF Financials

Key Financial Metrics (TTM)

Gross Margin

40.63%

Operating Margin

10.84%

Net Income Margin

2.43%

Return on Equity

5.91%

Return on Capital

12.55%

Return on Assets

2.25%

Earnings Yield

1.98%

Dividend Yield

0.67%

Payout Ratio

35.26%

Stock Overview

Market Cap

$1.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

67.37M

Volume

13.30K

Avg. Volume

219.477

Financials (TTM)

Gross Profit

£646.87M

Operating Income

£176.09M

EBITDA

£275.82M

Operating Cash Flow

£169.90M

Capital Expenditure

-£59.76M

Free Cash Flow

£110.14M

Cash & ST Invst.

£18.27M

Total Debt

£317.99M

Cvs Group Plc Performance Analysis

Cvs Group Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30GBP 708,346,709-3.8%
20242024-06-30GBP 804,068,15213.5%
20252025-06-30GBP 870,916,8108.3%
20262026-06-30GBP 956,713,2439.9%
Cvs Group Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-314.6%
Q42025-06-3070.4%
Q22025-12-31-38.7%
Q42026-06-300.3%
Cvs Group Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30GBP 0.7047.3%
20242024-06-30GBP 0.11-84.5%
20252025-06-30GBP 0.35219.6%
20262026-06-30GBP 0.33-6.0%
Cvs Group Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31245.5%
Q42025-06-30-6.3%
Q22025-12-31-26.7%
Q42026-06-3027.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

£357.81M

+9.5%

Gross Profit

£145.48M

+6.3%

Gross Margin

40.66%

N/A

Market Cap

$1.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$124.27K

N/A

Employees

9,000

N/A

Net Income

£9.55M

+213.7%

EBITDA

£74.70M

+8.5%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

£18.27M

+10.7%

Total Debt

£317.99M

+10.5%

Accounts Receivable

£99.48M

+79.2%

Inventory

£29.49M

-7.3%

Long Term Debt

£301.61M

+10.1%

Short Term Debt

£16.38M

+17.9%

Return on Assets

2.25%

N/A

Return on Invested Capital

12.05%

N/A

Free Cash Flow

£16.69M

+187.0%

Operating Cash Flow

£32.98M

-8.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SPI.LSpire Healthcare Group plc
£2.48+0.00%
PETS.LPets at Home Group Plc
£2.12+0.09%

Trending Stocks

Symbol / CompanyPricePrice Chg
BACBank of America
$49.81-7.69%
CRWVCoreWeave
$67.37-13.42%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$40.21+7.46%
SOFISoFi Technologies
$14.35-5.87%

Questions About CVSGF

What is the current price of Cvs Group Plc?

Cvs Group Plc is trading at $16.60 per share.

What is the 52-week range for Cvs Group Plc?

Over the past 52 weeks, Cvs Group Plc has traded between $14.50 and $17.22.

How much debt does Cvs Group Plc have?

As of the most recent reporting period, Cvs Group Plc reported total debt of £425.12M.

How much cash does Cvs Group Plc have on hand?

Cvs Group Plc reported £24.42M in cash and cash equivalents in its most recent financial results.

What is Cvs Group Plc’s dividend yield?

Cvs Group Plc currently has a dividend yield of 0.67%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services